Gene doping in sport

NewsGuard 100/100 Score

Professor John Rasko, head of the Gene and Stem Cell Therapy Program at the Centenary Institute, University of Sydney, talks about gene doping and other methods of performance enhancement on the eve of the 2008 Beijing Olympics.

Touching upon the mechanisms by which athletes can attempt to increase performance, such as blood doping and altitude training to increase the individual's oxygen carrying capacity, he goes on to discuss the use of hormones to stimulate the production of red blood cells in the body to improve performance.

Professor Rasko also talks about the new area of gene doping, which is achieved through the use of gene therapy technologies that have recently become more widely available.

Warning of the danger of 'over filling the tank', Rasko says that the increase in read blood cells in the body as a result of these therapies can led to stroke, cardiovascular accident also with clots in peripheral blood vessels leading to gangrene and other complications.

Finally, he touches upon new methods of detection and suggests that future methods of testing could even enable the doping agencies to detect if blood has been stored outside the body to avoid current testing methods.

Professor Rasko gave talk as part of the Australian Science Media Centre media briefing, entitled Drugs at the Olympics on 4 August 2008

A full recording is available online at: http://www.aussmc.org/JohnRasko040808.mp3

http://www.usyd.edu.au

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers receive NIH grant to help develop gene therapy for HIV